Summary
-
1.
Neurochemical, neuropharmacological, and neurophysiological sudies suggest that some of the so-called trace amines may have a role in the modulation of neurotransmission. This review examines the possible existence and characterization of brain binding sites for the trace amines.
-
2.
The results of radioligand binding studies carried out so far suggest the existence of tryptamine binding sites that possibly constitute a true functional receptor. This is supported by evidence obtained from the saturation studies, drug-mediated inhibition of binding, and the changes in the number of sites induced by pharmacological and lesion studies. In addition, the existence of a functional tryptamine binding site is supported by the increased neurophysiological responses of tryptamine obtained from the striatum of rat with unilateral substantia nigra lesions.
-
3.
It has been shown that the brain contains saturable binding sites forp-tyramine that appear to be related to the transport of dopamine into synaptic vesicles. There are, however, some questions with respect to the homogenization technique employed and some inconsistencies with respect to the number of binding sites estimated in neuronal membrane preparations.
-
4.
The existence ofp-octopamine binding sites has been demonstrated in crude membranes obtained from fruitflies but not shown so far in vertebrates.
-
5.
The presence of brain binding sites forβ-phenylethylamine are suggested but they are not so well defined and its physiological implication remains to be elucidated.
Similar content being viewed by others
References
Altar, C. A., Wasley, A. M., and Martin, L. L. (1986). Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain.Neuroscience 17263–273.
Axelrod, J., and Saavedra, J. M. (1974). Octopamine, phenylethanolamine, phenylethylamine and tryptamine in the brain. InAromatic Amino Acids in the Brain Ciba Foundation Symposium 2 (New Series), Elsevier-Excerpta Medica, North-Holland, Amsterdam, pp. 51–59.
Baldessarini, R. J. (1978). Trace amines and alternative neurotransmitters in the central nervous system.Biochem. Pharmacol. 27621–626.
Baldessarini, R. J., and Vogt, M. J. (1971). The uptake and subcellular distribution of aromatic amines in the brain of the rat.J. Neurochem. 182519–2533.
Boulton, A. A. (1974). Amines and theories in psychiatry.Lancet 252–53.
Boulton, A. A. (1976). Identification, distribution, metabolism and function ofmeta- andpara-tyramine, phenylethylamine and tryptamine in brain.Adv. Biochem. Psychopharmacol. 1557–67.
Boulton, A. A., and Baker, G. E. (1975). The subcellular distribution ofβ-phenylethylamine, tyramine and tryptamine in rat brain.J. Neurochem. 25477–481.
Boulton, A. A., and Juorio, A. V. (1982). Brain trace amines.In Handbook of Neurochemistry, Vol. 1, 2nd ed. (A. Lajtha, ed.), Plenum, New York and London, pp. 189–221.
Boulton, A. A., Wu, P. H., and Philips, S. (1972). Binding of some primary aromatic amines to certain rat brain particulate fractions.Can. J. Biochem. 501210–1218.
Bruning, G., and Rommelspacher, H. (1984). High affinity [3H]tryptamine binding sites in various organs of the rat.Life Sci. 341441–1446.
Cascio, C. S., and Kellar, J. K. (1983). Characterization of [3H]tryptamine binding sites in brain.Eur. J. Pharmacol. 9531–39.
Cascio, C. S., and Kellar, K. J. (1986). Effect of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.Eur. J. Pharmacol. 120101–105.
Charlton, K. G., Johnson, T. D., Maurice, R. W., and Clarke, D. E. (1985). Kynuramine: High affinity for [3H]tryptamine binding sites.Eur. J. Pharmacol. 106661–664.
Clineschmidt, B. V., and Lotti, V. J. (1974). Indolamine antagonists: Relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses.Brit. J. Pharmacol. 50311–313.
Cohen, A. I., and Blazynski, C. (1987). Tryptamine and some related molecules block the accumulation of a light-sensitive pool of cyclic AMP in the dark-adapted, dark-incubated mouse retina.J. Nuerochem. 48729–737.
Conn, P. J., and Sanders-Bush, E. (1985). Serotonin-stimulated phosphoinositide turnover: Mediation by the S2 binding in rat cerebral cortex but not in subcortical regions.J. Pharmacol. Exp. Ther. 234195–203.
Cox, B., Lee, T. F., and Martin, D. (1981). Different hypothalamic receptors mediate 5-HT and tryptamine-induced core temperature changes in the rat.Br. J. Pharmacol. 72477–482.
Creese, I., and Sibley, D. R. (1981). Receptor adaptation to centrally acting drugs. InAnnu. Rev. Pharmacol. Toxicol. 21357–391.
David, J.-C., and Coulon, J.-F. (1985). Octopamine in invertebrates and vertebrates.Prog. Neurobiol. 24141–185.
Dudai, Y. (1982). High-affinity octopamine receptors revealed inDrosophilia by binding of [3H]octopamine.Neurosci. Lett. 28163–167.
Dudai, Y., and Zvi, s. (1984). High-affinity [3H]octopamine binding sites inDrosophila melanogaster: Interaction with ligands and relationship to octopamine receptors.Comp. Biochem. physiol. 77C145–151.
Durden, D. A., Philips, S. R., and Boulton, A. A. (1973). Identification and distribution ofβ-phenylethylamine in the rat.Can. J. Biochem. 51995–1002.
Evans, P. D. (1981). Multiple receptor types for octopamine in the locust.J. Physiol. 31899–122.
Graham, D., and Langer, S. Z. (1987). [3H]tryptamine binding sites of rat cerebral cortex: Pharmacological profile and plasticity.Neuropharmacology 261093–1097.
Greenshaw, A. J., and Dewhurst, W. G. (1987). Tryptamine receptors: Fact, myth or misunderstanding?Brain Res. Bull. 18253–256.
Hashemzadeh, H., Hollingworth, R. M., and Voliva, A. (1985). Receptors for [3H]octopamine in the adult firefly light organ.Life Sci. 37433–440.
Hauger, R. L., Skolnick, P., and Paul, S. M. (1982). Specific [3H]β-phenylethylamine binding sites in rat brain.Eur. J. Pharmacol. 83147–148.
Jones, R. S. J. (1982). Tryptamine: A neuromodulator or neurotransmitter in mammalian brain?Prog Neurobiol. 19117–139.
Juorio, A. V. (1982). The effects of some antipsychotic drugs, d-amphetamine and reserpine on the concentration and rate of accumulation of tryptamine and 5-hydroxytryptamine in the mouse striatum.Can. J. Phys. Pharmacol. 60376–380.
Juorio, A. V. (1988). Brain trace amines: Mapping studies and effects of mesencephalic lesions. InTrace Amines: Comparative and Clinical Neurobiology (A. A. Boulton, A. V. Juorio, and R. G. H. Downer, Eds.), Humana Press, Clifton, N.J., pp. 157–174.
Juorio, A. V., and Durden, D. A. (1984). The distribution and turnover of tryptamine in the brain and spinal cord.Nuerochem. Res. 91283–1293.
Juorio, A. V., Greenshaw, A. J., and Ngugen, T. V. (1987). Effect of intranigral administration of 6-hydroxydopamine and 5,7-dihydroxytryptamine on rat brain tryptamine.J. Neurochem. 481346–1350.
Kaulen, P., Bruning, G., Rommelspacher, H., and Baumgarten, H.-G. (1986). Characterization and quantitative autoradiography of [3H]tryptamine binding sties in rat brain.Brain Res. 36672–88.
Kellar, K. J., and Cascio, C. S. (1982). [3H]Tryptamine: High affinity binding sites in rat brain.Eur. J. Pharmacol. 78475–478.
Kendall, D. A., and Nahorski, S. R. (1985). 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: Pharmacological characterization and effects of antidepressants.J. Pharmacol. Exp. Ther. 233473–479.
Kienzl, E., Riederer, P., Jellinger, K., and Noller, H. (1985). A physicochemical approach to characterise [3H]tryptamine binding sites in human brain. InNeuropsychopharmacology of the Trace Amines (A. A. Boulton, P. R. Bieck, L. Maitre, and P. Riederer, Eds.), Humana Press, Clifton, N.J., pp. 469–485.
Kopin, I. J. (1968). False adrenergic transmitters.Annu. Rev. Pharmacol. 8377–394.
Laduron, P. M. (1984). Criteria for receptor sites in binding studies.Biochem. Pharmacol. 33833–839.
Laduron, P. M. (1988). Stereospecificity in binding studies: A useful criterion though insufficient to prove the presence of receptors.Biochem. Pharmacol. 3737–40.
Martin, L. L., Roland, D. M., Neale, R. F., and Wood, P. L. (1986). Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranesin vitro by phenylethylamines.Eur. J. Pharmacol. 13253–55.
Martin, L. L., Neale, R. F., and Wood, P. L. (1987). Down-regulation of tryptamine receptors following chronic administration of clorgyline.Brain Res. 419239–243.
McCormack, J. K., Beitz, A. J., and Larson, A. A. (1986). Autoradiographic localization of tryptamine binding sites in the rat and dog central nervous system.J. Neurorsci. 694–101.
Nguyen, T. V., Paterson, I. A., Juorio, A. V., Greenshaw, A. J., and Boulton, A. A. (1989). Tryptamine receptors: Neurochemical and electrophysiological evidence for postsynaptic and functional binding sites.Brain Res. 47685–93.
Osborne, N. N. (1985). Tryptamine, tyramine and histamine immunoreactivities in specific neurones of the gastropod CNS. InNeuropsychopharmacology of the Trace Amines, (A. A. Boulton, P. R. Bieck, L. Maitre, and P. Riederer, Eds.), Humana Press, Clifton, N.J., pp. 115–124.
Osborne, N. N., Cutcliffe, N., and Peard, A. (1986). Trace amines (ethylamine, octopamine, and tryptamine) stimulate inositol phospholipid hydrolysis in rat cerebral cortex slices.Neurochem. Res. 111525–1531.
Overstreet, D. H., and Yamamura, H. I. (1979). Receptor alterations and drug tolerance.Life Sci. 251865–1878.
Perry, D. C. (1986). [3H]Tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.J. Pharmacol. Exp. Ther. 236548–559.
Perry, D. C. (1988). Comparison of the binding of [3H]tryptamine in rat brain with that of two ligands for monoamine oxidase, [3H]MPTP and [3H]pargyline. InTrace Amines: Their Comparative and Clinical Neurobiology, (A. A. Boulton, A. V. Juorio, and R. G. H. Downer, Eds.), Humana Press, Clifton, N. J., pp. 83–94.
Perry, D. C., Manning, D. C., and Snyder, S. H. (1982).In vitro autoradiographic localization of [3H]tryptamine binding sites in rat brain.Neurosci. Abstr. 8783.
Philips, S. R., and Boulton, A. A. (1979). The effect of monoamine oxidase inhibitors on some arylalkylamines in rat striatum.J. Neurochem. 33159–167.
Robertson, H. A., and Juorio, A. V. (1976). Octopamine and some related noncatecholic amines in invertebrate nervous systems. InInternational Review of Neurobiology, Vol. 19 (C. C. Pfeiffer and J. R. Smythies, Eds.), Academic Press, New York, pp. 173–224.
Ungar, F., Mosnaim, A. D., Ungar, B., and Wolf, M. E. (1977). Tyramine-binding by synaptosomes from rat brain: Effect of centrally active drugs.Biol. Psychiat. 12661–668.
Vaccari, A. (1986). High affinity binding of [3H]-tyramine in the central nervous system.Br. J. Pharmacol. 8915–25.
Vaccari, A. (1988). High affinity binding ofp-tyramine: A process in search of a function. InTrace Amines: Comparative and Clinical Neurobiology (A. A. Boulton, A. V. Juorio, and R. G. H. Downer Eds.), Humana Press, Clifton, N.J., pp. 119–132.
Wood, P. L., Pilapil, C., LaFaille, F., Nair, P. V., and Glennon, R. A. (1984). Unique [3H]tryptamine binding sites in rat brain: Distribution and pharmacology.Arch. Int. Pharmacodyn. 268194–201.
Wu, P. H., and Boulton, A. A. (1973). Distribution and metabolism of tryptamine in the rat brain.Can. J. Biochem. 511104–1112.
Wu, P. H., and Boulton, A. A. (1974). Distribution, metabolism and disappearance of intraventricularly injectedp-tyramine in the rat.Can. J. Biochem. 52374–381.
Wu, P. H., and Boulton, A. A. (1975). Metabolism, distribution an disappearance ofβ-phenylethylamine in the rat.Can. J. Biochem. 5342–50.
Xu, J., and Chuang, D.-M. (1987). Setonergic, adrenergic and histaminergic receptors coupled to phospholipase C in cultured cerebellar granule cells of rats.Biochem. Pharmacol. 362353–2358.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nguyen, T.V., Juorio, A.V. Binding sites for brain trace amines. Cell Mol Neurobiol 9, 297–311 (1989). https://doi.org/10.1007/BF00711411
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00711411